Big pharma is racing to produce an effective jab to counter a virus that has now killed more than 935,000 people around the world and infected almost 30 million.

Deaths in India due to coronavirus pandemic are less than many nations in Europe, he said, adding the government was determined to cross the US in testing rate as well.

Delhi has been witnessing a surge in novel coronavirus cases from the last week of August. Delhi recorded its biggest single-day jump of 4,321 fresh COVID-19 cases on Saturday, taking the city's tally to over 2.14 lakh, authorities said. It was for the fourth day in a row that over 4,000 fresh cases were recorded in Delhi.

Add to this new normal, ill-health, joblessness, financial crises and the everyday stresses that people anyway had to deal with and the COVID-19 tunnel stretches dark and seemingly endless with no light at the end of it.

The five states - Maharashtra, Tamil Nadu, Andhra Pradesh, Karnataka and Uttar Pradesh - account for 60 per cent of total 9,73,175 active cases in the country. The national recovery rate now stands at 77.88%.

On 9 September ANI first reported that DCGI issued a show-cause notice to Serum Institute for not pausing the ongoing clinical trial of the COVID-19 vaccine.

Stating that India's large number of primary healthcare centres and sub-centres are a huge opportunity for a grid waiting to happen'', she asked global majors in the solar technology sector to think about innovative solutions to apply their capability and talent to aid healthcare in the country.

According to the survey, 59 per cent of respondents said they want to availDigital Health ID' under the Digital Health Mission programme, but do not want to share sensitive personal data beyond health and medical records.

New Delhi, Sep 3 () Dr Reddy's Laboratories on Thursday said it has launched Methylphenidate Hydrochloride extended-release tablets, used to treat attention deficit disorder (ADD), in the US market.

To encourage broad patient access to this important medicine, Mylan is offering Semglee at a wholesale acquisition cost (WAC)[1] of $147.98 per package of five (5) 3ml pens and $98.65 per 10ml vial, representing the lowest WAC for any long-acting insulin glargine on the market, said Biocon in a press release.

We are finding new cases everyday, but the first thing we need to know is how many of them are serious, said Dileep Mavalankar, Director of the Gandhinagar-based Indian Institute of Public Health.

The number of fully immunised children fell by over 15 lakh in the three-month period from April to June compared to the same months last year. The number of institutional deliveries fell by about 13 lakh. The registered number of TB patients undergoing treatment fell to almost half of what it was last year. People seeking cancer treatment as outpatients fell by over 70%.

Maharashtra, accounting for almost 22% of Indias 34 lakh confirmed cases till Friday, continued to show a positivity rate of 20% over the last 14-day period, between August 14-27.

While the vaccine could be available at USD 3-6 (Rs 225 to Rs 550) per dose, herd immunity might be two years away due to implementation challenges, the brokerage said, adding the experience in large scale adult vaccination programmes is thin.

Traces of SARS-CoV-2 were detected in February on the sink, faucet and shower handle of a long-vacant apartment, researchers at the Chinese Center for Disease Control and Prevention said in a study published this month in Environment International. The contaminated bathroom was directly above the home of five people confirmed a week earlier to have Covid-19.

The researchers noted that airborne transmission by respiratory aerosol droplets produced during coughing and sneezing is the dominant mode of spreading for infectious diseases such as COVID-19.

The company posted a total revenue from operations of Rs 9,154.4 crore in FY20, up 0.5 per cent year-on-year, with international revenue of Rs 7,124 crore contributing 78 per cent to the total revenue, its annual report for fiscal year 2019-20 said.